Patent: 8,609,112
✉ Email this page to a colleague
Summary for Patent: 8,609,112
Title: | Botulinum toxin treatments of depression |
Abstract: | Methods for preventing or treating depression including a depression mediated by the thalamus. Depression, including a thalamically mediated depression, can be treated by peripheral administration of a botulinum toxin to or to the vicinity of a trigeminal sensory nerve, thereby preventing or treating the depression. |
Inventor(s): | Blumenfeld; Andrew M. (Del Mar, CA), Turkel; Catherine C. (Newport Coast, CA), Brin; Mitchell F. (Newport Beach, CA) |
Assignee: | Allergan, Inc. (Irvine, CA) |
Application Number: | 13/757,431 |
Patent Claims: | see list of patent claims |
Details for Patent 8,609,112
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Solstice Neurosciences, Llc | MYOBLOC | rimabotulinumtoxinb | Injection | 103846 | 12/08/2000 | ⤷ Try a Trial | 2023-10-29 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |